|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense, net and other income, net | |||||
| Interest expense, net | |||||
| Other income, net | |||||
| Total interest expense, net and other income, net | |||||
| (Loss) income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net (loss) income | |||||
| Net (loss) income per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares used to compute net (loss) income per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...